Loading clinical trials...
Loading clinical trials...
A Phase 2b, Extension Study to Determine the Long-term Safety of Vedolizumab IV in Pediatric Subjects With Ulcerative Colitis or Crohn's Disease
Conditions
Interventions
Vedolizumab
Locations
23
United States
Cedars-Sinai Medical Center
Los Angeles, California, United States
Children's Hospital of Orange County
Orange, California, United States
University of California San Francisco
San Francisco, California, United States
Connecticut Children's Medical Center
Hartford, Connecticut, United States
Nemours Childrens Specialty Care - Jacksonville
Jacksonville, Florida, United States
Children's Center for Digestive Healthcare
Atlanta, Georgia, United States
Start Date
July 30, 2018
Primary Completion Date
April 3, 2025
Completion Date
July 17, 2025
Last Updated
March 13, 2026
NCT07550673
NCT06226883
NCT05739864
NCT04338204
NCT07271069
NCT06975722
Lead Sponsor
Takeda
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions